SDTMs in Medical Devices A First Attempt

Slides:



Advertisements
Similar presentations
Monika Kawohl Principal Statistical Programmer Accovion
Advertisements

ADaM Implementation Guide: It’s Almost Here. Are You Ready?
Tips to a Successful Monitoring Visit
Adverse Events and Serious Adverse Events
Updates on CDISC Activities
Presentation of BE data in a product dossier Drs. Jan Welink Training workshop: Training of BE assessors, Kiev, October 2009.
UC5:Assigning of Epoch after treatment discontinuation (NS)
What’s New with CDISC Wayne R. Kubick CDISC CTO.
CDISC ADaM 2.1 Implementation: A Challenging Next Step in the Process Presented by Tineke Callant
Restricted © Business & Decision Life Sciences 2014 All rights reserved. Business & Decision Life Sciences How the release of the Therapeutic Area Asthma.
Quick tour of CDISC’s ADaM standard
Elke Sennewald Berlin, 28 September 2010 CDASH Tutorial.
An Introduction to Clinical Data Acquisition Standards Harmonization (CDASH) Loryn Thorburn © 2010 PAREXEL International | Confidential.
WUSS 2009 CDISC for the Medical Device and Diagnostic Industry: An Update Carey Smoak Team Leader CDISC Device SDTM Sub-team.
Bay Area CDISC Implmentation Network – July 13, 2009 How a New CDISC Domain is Made Carey Smoak Team Leader CDISC SDTM Device Team.
Diastolic Blood Pressure C25299 C25299 CDISC VSTESTCD = “DIABP” Blood Pressure C54706 The pressure of the circulating blood against the walls of the blood.
CDISC and how Stata can help us implement it
Accenture Accelerated R&D Standards Metadata Management – version control and its governance Kevin Lee CDISC NJ Meeting at 01/28/2015 We help our Clients.
23 August 2015Michael Knoessl1 PhUSE 2008 Manchester / Michael Knoessl Implementing CDISC at Boehringer Ingelheim.
Dominic, age 8, living with epilepsy SDTM Implementation Guide : Clear as Mud Strategies for Developing Consistent Company Standards PhUSE 2011 – CD02.
Trial Design in the CDISC World Albert Chau 26 July
CBER CDISC Test Submission Dieter Boß CSL Behring, Marburg 20-Mar-2012.
Adverse Events, Unanticipated Problems, Protocol Deviations & other Safety Information Which Form 4 to Use?
© 2011 Octagon Research Solutions, Inc. All Rights Reserved. The contents of this document are confidential and proprietary to Octagon Research Solutions,
© 2008 Octagon Research Solutions, Inc. All Rights Reserved. 2 Octagon Research Solutions, Inc. Leading the Electronic Transformation of Clinical R&D ©
CDASh : A Primer and Guide to Implementation
1CDISC 2002 RCRIM – Standard Domains Agenda NCI Presentation Standard Domains Working Group Goals Introduction to FDA Information Model (FIM) Discussion:
Overview and feed-back from CDISC European Interchange 2008 (From April 21 st to 25 th, COPENHAGEN) Groupe des Utilisateurs Francophones de CDISC Bagneux.
Update on SDTMIG v and SDTM v. 1.2 Bay Area User Group Meeting May 2008 Fred Wood Octagon Research Solutions.
Study design P.Olliaro Nov04. Study designs: observational vs. experimental studies What happened?  Case-control study What’s happening?  Cross-sectional.
MODULE B: Case Report Forms Jane Fendl & Denise Thwing April 7, Version: Final 07-Apr-2010.
15th Informal US MedDRA User Group Meeting, October 28, 2011 Slide 1 Double the Impact with Half the Work: Linking MedDRA and WHO Drug Indication coding.
Research Study Design. Objective- To devise a study method that will clearly answer the study question with the least amount of time, energy, cost, and.
RCRIM Projects: Protocol Representation and CDISC Message(s) January 2007.
How To Design a Clinical Trial
Updates on CDISC Activities
1. © CDISC 2014 Stetson Line, Team Lead CDISC Intrachange SDTM Rules Sub-team Update.
How good is your SEND data? Timothy Kropp FDA/CDER/OCS 1.
How Good is Your SDTM Data? Perspectives from JumpStart Mary Doi, M.D., M.S. Office of Computational Science Office of Translational Sciences Center for.
CDISC SDS Oncology Domains: An Orientation to Aid Review & Feedback Barrie Nelson CDISC SDS Oncology Sub Team Lead
Robyn Korn, MBA, RHIA, CPHQ HS225- Week 8 Overview of ICD-9-CM.
Longest Follow-up After Implantation of a Self-Expanding Repositionable Transcatheter Aortic Valve: Final Follow-up of the Evolut R CE Study Stephen Brecker,
CLINICAL TRIALS.
Event-Level Narrative
Safety of the Subject Cena Jones-Bitterman, MPP, CIP, CCRP
Clinical database management: From raw data through study tabulations to analysis datasets Thank you for your kind introduction, and the opportunity to.
How To Design a Clinical Trial
GCP AND MEDICAL DEVICES
Late breaking news in heart valve disease
Chapter 4 ICD-9-CM Medical Coding
Aparna Kulkarni, Data Scientist
Clinicaltrials.gov Update
FDA’s IDE Decisions and Communications
Secondary Uses Primary Use EHR and other Auhortities Clinical Trial
Safety of the Subject Cena Jones-Bitterman, MPP, CIP, CCRP
Accenture Accelerated R&D Standards Metadata Management – version control and its governance Kevin Lee CDISC NJ Meeting at 01/28/2015 We help our Clients.
Patient Medical Records
Why use CDISC for trials not submitted to regulators?
Traceability between SDTM and ADaM converted analysis datasets
Late Follow-Up from the PARTNER Aortic Valve-in-Valve Registry
Frequently asked questions
Patterns emerging from chaos
Aparna Kulkarni, Data Scientist
To change this title, go to Notes Master
Visualizing Subject Level Data in Clinical Trial Data
Five-Year Outcomes after Randomization to Transcatheter or Surgical Aortic Valve Replacement: Final Results of The PARTNER 1 Trial Michael J. Mack, MD.
Safety Analytics Workshop – Computational Science Symposium 2019
Atlantic Cardiovascular Patient Outcomes Research Team
PhUSE: Pooling WHODrug B3 Format
How Should We Select and Define Trial Estimands
Presentation transcript:

SDTMs in Medical Devices A First Attempt Phil Hall Distinguished Statistical Programmer Edwards Lifesciences Irvine, CA

Introduction CDISC now required for pharmaceutical trials No date set for medical device trials Medical device companies getting prepared

Agenda What are Medical Devices? Similarities with Pharmaceutical Studies Use of Device Specific Domains Differences of Medical Device Trials Procedure Data CEC Adjudicated Data Day 0 Future Work Questions

What is a Medical Device? A man-made device which is placed on, in or near the body to cure, treat, diagnose or prevent a disease. Phil Hall © 2017

Class I / II Medical Devices

Class III Medical Devices ON IN NEAR

SAPIEN 3 Transcatheter Heart Valve http://www.edwards.com/therapies/transcatheter-aortic-valve-replacement-tavr #WUSS16

Edwards Approach to SDTM Mapping CDISC Study Data Tabulation Model Implementation Guide (SDTM IG): Human Clinical Trials Version 3.2 Study Data Tabulation Model Implementation Guide for Medical Devices (SDTMIG-MD): Version 1.0 Keep as simple as possible Plan for the future Used proposed domains for V3.3

Edwards Approach to SDTM Mapping 1) Low hanging fruit AE, MH, LB, VS etc. Using SUPPxx 2) Cross-form domains DM, DS, SV 3) Others SDTM Consistency Committee Propose – Debate - Agree

94 square pegs into 25 round holes SDTM Mapping CRFs Informed Consent Demographics Medical History SF-36 SDTM Domains DM MH QS 94 square pegs into 25 round holes 94 round pegs into 25 square holes.

Challenges SDTMs designed for drug trials not medical devices Multiple correct answers

Domains Domain Type Domain Trial Design Domains TA, TD, TE, TI, TS, TV Special-Purpose Domains DM, SV Interventions General Observation Class CM Events General Observation Class AE, CE, DS, DV, HO, MH Findings EG, IE, DD, LB, MO, QS, RS, VS, FT Device Domains DE, DI, DT, DX Custom Domains XC, XP, YP

Trial Design Domains TA (Trial Arms) TD (Trial Disease Assessments) TE (Trial Elements) TI (Trial Inclusion / Exclusion Criteria) TS (Trial Summary Information) TV (Trial Visits)

Common Domains AE (Adverse Events) CM (Concomitant and Prior Medications) DD (Death Details) DM (Demographics) DS (Disposition) DV (Protocol Deviations) EG (ECG Results) FT (Functional Test – Proposed for V3.3)* IE (Inclusion / Exclusion Criteria Not Met) HO (Healthcare Encounters) LB (Laboratory Test Results) MH (Medical History) MO (Morphology) QS (Questionnaires) RS (Disease Response – currently only for oncology studies in V3.2 but being expanded for all indications in V3.3)** SV (Subject Visits) VS (Vital Signs) * What to Expect in SDTMIG v3.3, Fred Wood, PharmaSUG2015 http://www.pharmasug.org/proceedings/2015/DS/PharmaSUG-2015-DS14.pdf ** https://www.cdisc.org/foundational/qrs

Domains Domain Type Domain Trial Design Domains TA, TD, TE, TI, TS, TV Special-Purpose Domains DM, SV Interventions General Observation Class CM Events General Observation Class AE, CE, DS, DV, HO, MH Findings EG, IE, DD, LB, MO, QS, RS, VS, FT Device Domains DE, DI, DT, DX Custom Domains XC, XP, YP #WUSS17

Device Specific Domains Study Data Tabulation Model Implementation Guide for Medical Devices (SDTMIG-MD): Version 1.0 Seven Domains Study Device Identifiers (DI)* Device In-Use (DU) Device Exposure (DX)* Device Events (DE)* Device Tracking and Disposition (DT)* Device-Subject Relationships (DR) Device Properties (DO)

Study Device Identifiers (DI)* The primary purpose of this domain is to provide a consistent sponsor-defined variable (SPDEVID) for linking data across Device domains. Device Identifiers exist independently from subjects and therefore the Study DI domain does not contain USUBJID.

Device In-Use (DU) Device In-Use is a Findings domain that contains the values of measurements and settings that are intentionally set on a device when it is used, and may vary from subject to subject or other target. These are characteristics that exist for the device, and have a specific setting for a use instance.

Device Exposure (DX)* Device Exposure is an Interventions domain that records the details of a subject’s exposure to a medical device under study.

Device Events (DE)* DE is an Events domain that contains information about various kinds of device-related events, such as device malfunctions.

Device Tracking and Disposition (DT)* The Device Tracking and Disposition domain is an Events domain that represents a record of tracking events for a given device. This could include initial shipment, deployment, return, destruction, etc.

Device-Subject Relationships (DR) The Device-Subject Relationships domain is a special-purpose domain that links each subject to devices to which they may have been exposed.

Device Properties (DO) The Device Properties Findings domain is used to report characteristics of the device that are important to include in the submission, do not vary over the course of the study but are not used to identify the device. Examples include expiration date or shelf life.

Procedure Data Options PR Domain Device-specific Domain Custom Domain

PR Domain PR – Assumptions for the Procedures Domain Model The Procedures domain model reflects collected details describing a subject’s therapeutic and diagnostic procedures. Some example procedures by type include the following: a. disease screening b. endoscopic examinations c. diagnostic tests d. therapeutic procedures e. surgical procedures (e.g., curative surgery, diagnostic surgery, palliative surgery, therapeutic surgery, prophylactic surgery, resection, stenting, hysterectomy, tubal ligation, implantation) CDISC Study Data Tabulation Model Implementation Guide (SDTM IG): Human Clinical Trials Version 3.2

Procedure Data Standardized Procedure Name Start Date/Time of Procedure End Date/Time of Procedure Study Day of Start of Procedure Study Day of End of Procedure Subject treated according to assignment Intended Approach Actual Approach Valve Size (mm) Type of anesthesia used Anesthesia Start Datetime Anesthesia Stop Datetime Specify Procedure aborted reason

X Procedure Data Options PR Domain Device-specific Domain Custom Domain X

Adjudicated Data Clinical Endpoint Committee (CEC) Independent panel of experts reviewing clinical data to give expert opinion on certain events of interest. More common in medical devices but not unique Examples Disabling / Non-disabling Stroke Cardiovascular / Non-cardiovascular Mortality Re-hospitalization Due to Valve-related Symptoms

Adjudicated Data Options Add to AE Domain CE (Clinical Events) Domain A dataset used to capture clinical events of interest that would not be classified as adverse events. Custom Domain

X X Adjudicated Data Options Add to AE Domain Not a 1-to-1 relationship CE (Clinical Events) Domain Custom Domain X X

Day 0 vs Day 1 Medical Devices Day of Implant Procedure = Day 0 Pharmaceutical Day of First Dose = Day 1

Domains Domain Type Domain Trial Design Domains TA, TD, TE, TI, TS, TV Special-Purpose Domains DM, SV Interventions General Observation Class CM Events General Observation Class AE, CE, DS, DV, HO, MH Findings EG, IE, DD, LB, MO, QS, RS, VS, FT Device Domains DE, DI, DT, DX Custom Domain XC, XP, YP

Custom Domains The ‘Other, specify’ of domains Case Review (XC) Concomitant Procedures (XP) Procedure (YP)

Deviations From Standards No 200 character limit Limited recoding Day 0 No EX domain Spend the time updating CRFs

Summary of Advice Use basic pharma domains where obvious to use AE, MH, VS, LB etc. Create trial design domains Use device-specific domains where appropriate Use CE domain for adjudicated data Use custom domains for anything else Can’t be CDISC compliant without proper CRFs so keep first attempt simple

Future Work CRFs – CDASH New / Updated Domains DP / PR Pinnacle 21 / Open CDISC accommodations Second Attempt

Questions? ?

Contact Details Phil Hall Edwards Lifesciences One Edwards Way Irvine CA 92614 949-250-4881 Phil_Hall@Edwards.com #WUSS17 38 #WUSS14